The Study
Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study
This study looked at people who were already taking statins and compared them to people who weren’t, then saw what happened to their blood sugar and heart health over time. It didn’t make anyone take statins — it just watched what happened naturally. So we can say statins were linked to better heart outcomes, but we can’t say statins caused them.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
People with type 2 diabetes who were already taking statins before starting insulin had slightly worse blood sugar control at first, but were much less likely to have heart attacks, strokes, or die.
Where does this study sit?
Systematic Reviews & Meta-analyses
Max 100Randomized Trials
Max 90Cohort Studies
Max 72Case-Control
Max 58Cross-Sectional
Max 44Case Reports & Series
Max 30Expert Opinion
Max 559 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — even though statins slightly slowed blood sugar improvement, they cut major heart problems by nearly one-third, which is a big benefit for high-risk diabetics.
- 2At 6 months, blood sugar dropped 0.34% without statins vs 0.26% with statins.
- 3After 3 years, both groups were similar.
- 4Statin users had 36% fewer heart attacks, strokes, or deaths over 5 years.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Cardiovascular Diabetology
Year
2017
Authors
U. Anyanwagu, J. Mamza, R. Donnelly, I. Idris
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.